U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07192341) titled 'Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction' on Sept. 17.
Brief Summary: This study aims to evaluate the effect of sacubitril/valsartan in patients with prosthetic heart valves with heart failure with reduced ejection fraction (HFrEF).
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Sacubitril/Valsartan
Prosthetic Heart Valve
Heart Failure
Reduced Ejection Fraction
Intervention:
DRUG: Sacubitril/Valsartan
Patients will be treated with conventional anti-heart failure therapy plus sacubitril/valsartan (oral administration of an initial dose of ...